Type | Feature | Pooled prevalence of stunting, %(95% CI, I2, P value) | Pooled prevalence of under-weight, % (95% CI, I2, P value) | Pooled prevalence of wasting, %(95% CI, I2, P value) |
---|---|---|---|---|
Sub-group analysis by country | Ethiopia | 41.83 (26.83–56.84, 99.1, <  0.01) | 33.62 (25.04–42.20, 95.0, <  0.01) | 21.24 (13.56–28.93, 95.9, <  0.01) |
Tanzania | 48.10 (39.05–57.15, 95.4, <  0.01) | 24.11 (10.88–37.33, 97.9, <  0.01) | 15.07 (0.52–29.62, 98.3, <  0.01) | |
Nigeria | 41.18 (29.60–25.77, 92.7, <  0.01) | 33.83 (11.81–55.85, 98, <  0.01) | 32.05 (12.49–51.61, 97.5, <  0.01) | |
Mozambique* | 57.40 (49.21–65.59, −) | 47.10 (38.91–55.29, −) | 18.60 (10.41–26.79, −) | |
Central Africa* | 32.90 (30.39–35.40, −) | 36.00 (33.49–38.51, −) | 16.50 (13.99–19.00, −) | |
Burkina Faso* | 29.90 (22.89–36.90, −) | 11.60 (4.59–18.61, −) | 10.40 (3.39–17.41, −) | |
Cameroon | 65.56 (52.82–78.29, 86.7, <  0.01) | 48.16 (36.06–60.26, 85.3, <  0.01) | 29.24 (7.00–51.47, 95.8, <  0.01) | |
Senegalese* | 42.00 (35.80–48.19, −) | – | 52.00 (45.81–58.19, −) | |
South Africa | 51.48 (7.99–94.97, 95.7, <  0.01) | 31.12 (7.36–69.60, 94.5, <  0.01) | 15.52 (4.85–26.19, 40.7, 0.194) | |
Kenya* | 50.90 (46.15–55.64, −) | 26.50 (21.75–31.25, −) | 13.60 (8.85–18.35, −) | |
Malawi* | 69.10 (64.35–73.85, −) | 51.80 (47.05–56.55, −) | – | |
Equatorial Guinea* | 56.30 (49.64–62.96, −) | 56.30 (49.64–62.96, −) | 27.70 (21.04–34.36, −) | |
Mali* | 20.00 (15.53–24.47, −) | – | 31.50 (27.03–35.97, −) | |
Uganda | 48.51 (11.17–85.84, 92.6, <  0.01) | 40.19 (18.57–61.80, 78.1, <  0.01) | 4.00 (12.42–20.42, −) | |
Rwanda* | 60.00 (55.03–64.96, −) | 24.0 (19.04–28.97,-) | 11.00 (6.04–5.97, −) | |
Sub-group analysis by study design | Cross-sectional | 49.8 (42.5–57.0, 97.8) | 35.29 (29.70–40.87, 95.9) | 22.15 (16.29–28.00, 96.1) |
Cohort | 48.7 (39.7–57.8, 97.6) | 44.89 (35.93–53.86, 97.2) | 27.55 (20.99–34.11, 95.3) | |
Sub-group analysis by publication year | January 2010-december 2015 | 50.48 (44.19–56.77, 95.9,<  0.01) | 34.82 (28.99–40.65, 95.1, <  0.01) | 17.67 (11.45–23.89, 95.3, <  0.01) |
January 2016-aguest 2021 | 43.79 (33.998–53.575, 99.1, <  0.01) | 36.93 (28.03–45.83, 98.3,<  0.01) | 26.97 (21.37–32.58, 96.8, <  0.01) |